Bristol Myers holds on to blockbuster Sotyktu hopes, plays down Otelza threat zbecker Thu, 02/02/2023 – 13:22 More: Bristol Myers holds on to blockbuster Sotyktu hopes, plays down Otelza threat Source: fierce
read moreAmid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro fkansteiner Thu, 02/02/2023 – 11:20 More: Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro Source: fierce
read moreRoche taps insider Graham for top pharma job as setbacks prompt M&A questions aliu Thu, 02/02/2023 – 10:46 More: Roche taps insider Graham for top pharma job as setbacks prompt M&A questions Source: fierce
read moreMerck’s recent Keytruda label expansion in NSCLC is more of a ‘long-term’ opportunity, CEO says kdunleavy Thu, 02/02/2023 – 10:43 More: Merck's recent Keytruda label expansion in NSCLC is more of a 'long-term' opportunity, CEO says Source: fierce
read moreBioNTech wraps up construction at German plant, expects full operations to start later this year esagonowsky Thu, 02/02/2023 – 09:19 More: BioNTech wraps up construction at German plant, expects full operations to start later this year Source: fierce
read moreThe central focus of the agreement is to establish peptide hits from selected library populations More: Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals